Dr. James Gulley is an attending physician, Genitourinary Malignancies Clinical Research Section, director of the Clinical Traials Group in the Laboratory of Tumor Immunology and Biology, and the senior staff clinician of the Medical Oncology Branch at the Center for Cancer Research National Cancer Institute at the National Institutes of Health.

Dr. Gulley graduated from Loma Linda University in California with a PhD in microbiology in 1994 and an MD in 1995. As part of this eight-year MD/PhD Medical Scientist Training Program, designed and funded by the NIH to produce translational researchers, he completed a dissertation on tumor immunology. He completed his residency in internal medicine at Emory University in 1998, followed by a medical oncology fellowship at the NCI. Since 1999 he has authored and run a variety of clinical trials at the NCI, serving as Principal Investigator or an Associate Investigator on approximately 40 trials. 

Dr. Gulley is especially interested in immunotherapy for prostate cancer. As director of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology, he takes promising laboratory findings and uses them to design and conduct clinical trials.  These studies involve the use of cancer vaccines and other immunostimulatory molecules to modulate the immune response in cancer patients, and the addition of other strategies to enhance vaccine-mediated killing. He has authored aprroximately100 scientific papers and book chapters, edited 3 books and has made numerous presentations at national and international meetings.